Clinical Biophysics International Research Group, Lugano, Switzerland.
Institute of Translational Pharmacology, National Research Council-CNR, Rome, Italy.
Int Urol Nephrol. 2019 Aug;51(8):1395-1401. doi: 10.1007/s11255-019-02212-3. Epub 2019 Jul 1.
Chronic Kidney Disease (CKD) and its clinical evolution are an emerging issue, due to an increasingly aging population. Consequently, the evaluation of integrative strategies to manage the decline in renal function is warranted. The previous evidence indicates that a biophysical integrated approach can significantly improve renal function. Nevertheless, controlled trials assessing the clinical efficacy of this strategy are still needed.
A 12-month controlled study was designed to assess the clinical outcome of a group of elderly patients affected by stage II/IIIa CKD randomly assigned to either control or biophysical treatment. In addition to the standard treatment with renin-angiotensin-aldosterone system inhibitors, the biophysical group underwent electromagnetic information transfer through aqueous system procedure every 3 months. Estimated glomerular filtration rate (eGFR), according to CKD-epidemiology collaboration formula, was calculated at baseline and every 3 months.
A total of 238 patients were included in the study, 118 (73.9 ± 3.8 years) in the biophysical therapy group and 120 (74.6 ± 4.2 years) in the control group. At baseline, mean eGFR was 69 ± 11.8 ml/min in the biophysical group and 70.7 ± 11.5 ml/min in the control group. After 1 year, eGFR was 74.1 ± 12.3 ml/min in the biophysical group, compared to 66.3 ± 11.9 ml/min in the control group, with a statistically significant difference between groups (p < 0.0001). The observed improvement in eGFR in the biophysical group was independent of age, gender, and antihypertensive treatment.
This study shows a potential contribution of a biophysical integrated strategy to support renal function against its natural decline in the elderly, warranting further clinical evaluation.
慢性肾脏病(CKD)及其临床进展是一个新出现的问题,这是由于人口老龄化日益加剧所致。因此,有必要评估综合策略来管理肾功能下降。先前的证据表明,生物物理综合方法可以显著改善肾功能。然而,仍需要评估这种策略的临床疗效的对照试验。
设计了一项为期 12 个月的对照研究,以评估一组随机分为对照组或生物物理治疗组的老年 II/IIIa 期 CKD 患者的临床结局。除了标准的肾素-血管紧张素-醛固酮系统抑制剂治疗外,生物物理组每 3 个月接受一次通过水系统程序的电磁信息传递。根据 CKD 流行病学合作公式计算肾小球滤过率估计值(eGFR),基线和每 3 个月测量一次。
共有 238 名患者纳入研究,生物物理治疗组 118 名(73.9±3.8 岁),对照组 120 名(74.6±4.2 岁)。基线时,生物物理组的平均 eGFR 为 69±11.8ml/min,对照组为 70.7±11.5ml/min。治疗 1 年后,生物物理组的 eGFR 为 74.1±12.3ml/min,对照组为 66.3±11.9ml/min,两组间差异有统计学意义(p<0.0001)。生物物理组 eGFR 的改善与年龄、性别和降压治疗无关。
本研究表明,生物物理综合策略可能有助于支持老年人肾功能,防止其自然下降,值得进一步临床评估。